2022
DOI: 10.1136/bcr-2021-248385
|View full text |Cite
|
Sign up to set email alerts
|

Superwarfarin poisoning: challenges still remain

Abstract: Superwarfarin (long-acting anticoagulant rodenticide) poisoning should be suspected in unexplained bleeding with prolonged prothrombin time, especially in the absence of another explanation. Diagnosis and treatment of this intoxication remain a challenge as the direct analysis of superwarfarin in serum is not always possible. Therefore, toxin bioavailability remains unknown and close monitoring and treatment for long periods are required to avoid serious bleeding complications. Here, we discuss a case of suspe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Some of the clinical manifestations of AR poisoning include systemic mucosal and organ bleeding, common hematuria, skin ecchymosis, gingival bleeding, gastrointestinal bleeding, epistaxis, and hemoptysis. [ 10 , 11 ] ARs inhibit the production of vitamin K by inhibiting the activity of vitamin K 2, 3-epoxide reductase. In addition, the glutamic acid residues of vitamin K-dependent coagulins cannot be carboxylated, thus affecting the activation of coagulation factor II, VII, IX, and X, making them unable to exert their coagulant activity.…”
Section: Discussionmentioning
confidence: 99%
“…Some of the clinical manifestations of AR poisoning include systemic mucosal and organ bleeding, common hematuria, skin ecchymosis, gingival bleeding, gastrointestinal bleeding, epistaxis, and hemoptysis. [ 10 , 11 ] ARs inhibit the production of vitamin K by inhibiting the activity of vitamin K 2, 3-epoxide reductase. In addition, the glutamic acid residues of vitamin K-dependent coagulins cannot be carboxylated, thus affecting the activation of coagulation factor II, VII, IX, and X, making them unable to exert their coagulant activity.…”
Section: Discussionmentioning
confidence: 99%